Astrazeneca is in trouble
The government may seek to phase out Astrazeneca, most likely due to the sheer amount of bad press and lack of consumer confidence. Meanwhile, the MSN is starting to report of Pfizer adverse events.
The government may seek to phase out Astrazeneca, most likely due to the sheer amount of bad press and lack of consumer confidence. Meanwhile, the MSN is starting to report of Pfizer adverse events.
No live chat option available on this video.
Everyday private media is looking more and more like state-controlled media. From unfounded COVID-19 fear mongering, to selective reporting, to pushing narratives that only seek to divide, the need has never been greater for media that challenges the status quo.
and then
Be the first to comment